May 19, 2026
The Patent Trial and Appeal Board will no longer conduct an inter partes review into the validity of an Omni MedSci wearable device patent, now that there will be a separate post-grant review.
May 08, 2026
Wearable technology company Whoop Inc. has shown that an Omni Medsci Inc. patent can be challenged under the America Invents Act because its effective filing was after a cutoff date in the law, U.S. Patent and Trademark Office Director John Squires has found.
February 04, 2026
The latest summary decision from U.S. Patent and Trademark Office Director John Squires denied 23 America Invents Act petitions and instituted 12 others, bringing his total number of patent challenges granted to 60.
December 02, 2025
U.S. Patent and Trademark Office Director John Squires has instituted four inter partes reviews and two post-grant reviews, the first Patent Trial and Appeal Board challenges to get his sign-off since he took over the institution review process.